Literature DB >> 23812455

Trends in hospital volume and patterns of referral for women with gynecologic cancers.

Jason D Wright1, Alfred I Neugut, Sharyn N Lewin, Yu-Shiang Lu, Thomas J Herzog, Dawn L Hershman.   

Abstract

OBJECTIVE: To estimate trends in hospital volume and referral patterns for women with uterine and ovarian cancer.
METHODS: The Surveillance, Epidemiology, and End Results-Medicare database was used to identify women aged 65 years or older with ovarian and uterine cancer who underwent surgery from 2000 to 2007. "Volume creep," when a greater number of patients undergo surgery at the same hospitals, and "market concentration," when a similar overall number of patients undergo a procedure but at a smaller number of hospitals, were analyzed.
RESULTS: Among 4,522 patients with ovarian cancer, mean hospital volume increased from 3.1 cases during 2000-2001 to 3.4 cases during 2006-2007 (P=.62) suggesting minimal volume creep. Similarly, there was little evidence of market concentration. In 2000-2001, 37.8% of women were treated at the top decile by volume hospitals compared with 41.4% in 2006-2007 (P=.14). In 2006-2007, 201 (63.2%) of the hospitals had an ovarian cancer surgery volume of two or fewer cases. Among 9,908 women with uterine cancer, the mean hospital volume increased slightly from 4.5 in 2000-2001 to 5.4 in 2006-2007 (P=.10). The percentage of patients treated at the top decile by volume of hospitals increased from 40.4% in 2000-2001 to 44.7% in 2006-2007 (P<.001). In 2006-2007, 243 (49.3%) of the hospitals had a uterine cancer surgery volume of two or fewer cases.
CONCLUSION: There have been only modest changes in the referral patterns of women with ovarian and uterine cancer. A large number of hospitals have a very low procedural volume.

Entities:  

Mesh:

Year:  2013        PMID: 23812455      PMCID: PMC4607280          DOI: 10.1097/AOG.0b013e31828ec686

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.

Authors:  Kemi M Doll; Ke Meng; Paola A Gehrig; Wendy R Brewster; Anne-Marie Meyer
Journal:  Am J Obstet Gynecol       Date:  2016-04-26       Impact factor: 8.661

2.  Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.

Authors:  Ayesha B Alvero; Michele K Montagna; Natalia J Sumi; Won Duk Joo; Emma Graham; Gil Mor
Journal:  Oncotarget       Date:  2014-09-30

Review 3.  Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1).

Authors:  Muhammad Wasif Saif; Andrew Heaton; Kimberley Lilischkis; James Garner; David M Brown
Journal:  Cancer Chemother Pharmacol       Date:  2016-12-24       Impact factor: 3.333

4.  Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.

Authors:  Sun Hee Rim; Shawn Hirsch; Cheryll C Thomas; Wendy R Brewster; Darryl Cooney; Trevor D Thompson; Sherri L Stewart
Journal:  World J Obstet Gynecol       Date:  2016-05-10

5.  Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation.

Authors:  Kahren M White; Holly Seale; Reema Harrison
Journal:  BMC Public Health       Date:  2019-03-12       Impact factor: 3.295

6.  Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.

Authors:  Kristin S Weeks; Charles F Lynch; Michele M West; Ryan M Carnahan; Michael A O'Rorke; Jacob J Oleson; Megan E McDonald; Mary E Charlton
Journal:  Am J Clin Oncol       Date:  2021-10-01       Impact factor: 2.787

7.  Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.

Authors:  Martinez Alejandra; Witold Gertych; Christophe Pomel; Gwenael Ferron; Amelie Lusque; Martina Aida Angeles; Eric Lambaudie; Roman Rouzier; Naoual Bakrin; Francois Golfier; Olivier Glehen; Michel Canis; Nicolas Bourdel; Nicolas Pouget; Pierre-Emmanuel Colombo; Frédéric Guyon; Jacques Meurette; Denis Querleu
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.